Heat treatment of benign prostatic hyperplasia

Duhamel G
Record ID 31996008278
Authors' objectives:

To define recommendations for evaluation procedures concerning appliances using hyperthermia to treat benign prostatic hyperplasia at the request of the French Ministry of Social Affairs and the French National Committee for Medical Evaluation.

Authors' results and conclusions: Two protocols were studied: CEDIT-APHP survey (efficacy of 6 different apparatuses versus placebo, evaluation by flowmetry, tansrectal ultrasonography, post-voiding residue) and GIE Lithotritie Diffusion France protocol (efficacy of a single apparatus versus placebo). The preclinical and clinical data may not allow comparison of the various apparatuses available and may not comply with legislation concerning biomedical research. The endpoints of the studies underway have not been clearly defined.
Authors' recommendations: Before being routinely used in clinical practice, all hyperthermia apparatuses must be submitted to approval procedures including technical tests demonstrating histologically proven tissue destruction, double-blind clinical trials of safety and efficacy versus reference treatment. Refunding of these treatments by Social Security would increase medical expenditure. Other output or dissemination activity: Not covered by health insurers.
Authors' methods: Review
Project Status: Completed
URL for project: http://cedit.aphp.fr/
Year Published: 1991
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: France
MeSH Terms
  • Hyperthermia, Induced
  • Prostatic Hyperplasia
Organisation Name: L'Agence Nationale d'Accreditation d'Evaluation en Santé
Contact Address: 2 avenue du Stade de France, 93218 Saint-Denis La Plaine Cedex, France. Tel: +33 01 55 93 71 88; Fax: +33 01 55 93 74 35;
Contact Name: sh.leerobin@has-sante.fr
Contact Email: sh.leerobin@has-sante.fr
Copyright: Agence Nationale pour le Developpement de l'Evaluation Medicale
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.